Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression

Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression

US Patent 9326972 · Granted May 3, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices and methods for classifying diabetic and macular degeneration2020
Imidazole and thiazole compositions for modifying biological signaling2020
Sensitive and rapid methods of using chimeric receptors to identify autoimmune d2020
Sensitive and rapid methods of using chimeric receptors to identify autoimmune d2020
Imidazole and thiazole compositions for modifying biological signaling2019
Prevention and treatment of non-alcoholic fatty liver disease2019
Prevention and treatment of non-alcoholic fatty liver disease2019
Prevention and treatment of non-alcoholic fatty liver disease2019
Imidazole and thiazole compositions for modifying biological signaling2018
Sensitive and rapid methods of using chimeric receptors to identify autoimmune d2017
Sensitive and rapid methods of using chimeric receptors to identify autoimmune d2017
Prevention and treatment of non-alcoholic fatty liver disease2017